Insider Transactions in Q3 2025 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2025
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
871
-0.58%
|
$16,549
$19.11 P/Share
|
|
Sep 08
2025
|
Jason Drew Smith General Counsel |
SELL
Open market or private sale
|
Direct |
1,520
-3.39%
|
$28,880
$19.11 P/Share
|
|
Sep 07
2025
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+1.1%
|
-
|
|
Sep 07
2025
|
Jason Drew Smith General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+6.92%
|
-
|
|
Aug 11
2025
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.32%
|
$170,000
$17.69 P/Share
|
|
Jul 28
2025
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,149
-3.15%
|
$97,831
$19.14 P/Share
|
|
Jul 28
2025
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.77%
|
-
|
|
Jul 28
2025
|
Jason Drew Smith General Counsel |
SELL
Open market or private sale
|
Direct |
7,522
-15.35%
|
$142,918
$19.14 P/Share
|
|
Jul 28
2025
|
Jason Drew Smith General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+25.19%
|
-
|